Royal London Asset Management LTD Merck & Co., Inc. Transaction History

Royal London Asset Management LTD

$38.5 Billion
Q2 2024

A detailed history of Royal London Asset Management LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Royal London Asset Management LTD holds 1,193,981 shares of MRK stock, worth $136 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

1,193,981

Previous 1,142,783 4.48%

Holding current value

$136 Million

Previous $151 Million 1.97%

% of portfolio

0.38%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$123.8 - $132.96 $6.34 Million - $6.81 Million	51,198 Added 4.48%	1,193,981 $148 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $114,485 - $133,401	-1,011 Reduced 0.09%	1,142,783 $151 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $2.39 Million - $2.6 Million	23,830 Added 2.13%	1,143,794 $125 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $5.66 Million - $6.29 Million	55,012 Added 5.17%	1,119,964 $115 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $16.2 Million - $17.6 Million	148,727 Added 16.23%	1,064,952 $123 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $2.23 Million - $2.49 Million	21,653 Added 2.42%	916,225 $97.5 Million
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $1.9 Million - $2.43 Million	21,693 Added 2.49%	894,572 $99.2 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $4.59 Million - $5.15 Million	-54,262 Reduced 5.85%	872,879 $75.2 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $348,988 - $395,595	4,180 Added 0.45%	927,141 $84.7 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $3.24 Million - $3.63 Million	44,009 Added 5.01%	922,961 $75.7 Million
Q4 2021 Oct 18, 2022	SELL	$72.28 - $90.54 $2.01 Million - $2.52 Million	-27,826 Reduced 3.07%	878,952 $67.4 Million
Q4 2021 Jan 18, 2022	SELL	$72.28 - $90.54 $2.01 Million - $2.52 Million	-27,826 Reduced 3.07%	878,952 $67.4 Million
Q3 2021 Oct 18, 2022	SELL	$71.68 - $78.83 $653,434 - $718,614	-9,116 Reduced 1.0%	906,778 $68.1 Million
Q3 2021 Nov 02, 2021	SELL	$71.68 - $78.83 $653,434 - $718,614	-9,116 Reduced 1.0%	906,778 $68.1 Million
Q2 2021 Oct 18, 2022	SELL	$70.31 - $77.77 $790,776 - $874,679	-11,247 Reduced 1.21%	915,894 $71.2 Million
Q2 2021 Jul 14, 2021	SELL	$70.31 - $77.77 $1.02 Million - $1.13 Million	-14,550 Reduced 1.56%	915,894 $71.2 Million
Q1 2021 Oct 17, 2022	BUY	$68.86 - $81.11 $227,444 - $267,906	3,303 Added 0.36%	930,444 $71.7 Million
Q1 2021 Apr 13, 2021	BUY	$68.86 - $81.11 $541,583 - $637,930	7,865 Added 0.85%	930,444 $71.7 Million
Q4 2020 Jan 29, 2021	SELL	$71.77 - $79.65 $3.5 Million - $3.88 Million	-48,735 Reduced 5.02%	922,579 $75.4 Million
Q3 2020 Nov 04, 2020	SELL	$73.18 - $82.95 $409,661 - $464,354	-5,598 Reduced 0.57%	971,314 $79.5 Million
Q2 2020 Jul 31, 2020	SELL	$70.42 - $80.13 $2.53 Million - $2.88 Million	-35,899 Reduced 3.54%	976,912 $74.4 Million
Q1 2020 May 01, 2020	SELL	$63.36 - $87.82 $466,709 - $646,882	-7,366 Reduced 0.72%	1,012,811 $77.9 Million
Q4 2019 Feb 05, 2020	BUY	$77.58 - $87.54 $864,629 - $975,633	11,145 Added 1.1%	1,020,177 $92.9 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $1.38 Million - $1.5 Million	-18,084 Reduced 1.76%	1,009,032 $84.9 Million
Q2 2019 Jul 31, 2019	SELL	$69.84 - $81.59 $1.2 Million - $1.4 Million	-17,203 Reduced 1.65%	1,027,116 $86.1 Million
Q1 2019 Apr 30, 2019	SELL	$69.58 - $79.36 $5.22 Million - $5.96 Million	-75,065 Reduced 6.71%	1,044,319 $0
Q4 2018 Jan 29, 2019	BUY	$65.24 - $75.71 $3.96 Million - $4.59 Million	60,684 Added 5.73%	1,119,384 $84.4 Million
Q3 2018 Nov 08, 2018	SELL	$57.69 - $67.84 $4.56 Million - $5.36 Million	-79,057 Reduced 6.95%	1,058,700 $0
Q2 2018 Sep 19, 2018	BUY	$50.83 - $59.72 $57.8 Million - $67.9 Million	1,137,757 New	1,137,757 $69.1 Million

Others Institutions Holding MRK

# of Institutions

3,831

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Merck & Co., Inc. Transaction History